5.6.5.3. compression devices males. 5.6.5.3.1. artificial urinary sphincter mechanism action: aus standard treatment moderate-to-severe male sui. ams 800 three component system inflatable cuff, control pump pressure regulating balloon device longest follow-up greatest level evidence . zsi 375 two-component device, inflatable cuff, control pump, allowing easier implantation process . aus devices launched e.g., victo br-sl-as 904 systems robust evidence regarding efficacy safety pending . efficacy meta-analysis 33 cohort studies one rct, reported significant improvement aus implantation overall cure rates (56%) reductions pad used per 24-hours (-3.75) . several observational studies reported functional outcomes ams 800. social continence rates (0-1 pads used daily) ranged 55-76.8% [706-708]. 77.2% continence rate 89.5% subjective satisfaction rate reported median follow-up > fifteen years 57 men undergone aus placement . prospective cohort study 40 patients mean follow-up 53 months, showed urodynamic parameters low bladder compliance negative impact outcome . however, another retrospective study showed urodynamic factors adversely altered outcome aus implantation . multicentre studies confirmed older statements surgeon’s experience higher surgical volume associated better outcomes lower revision rate aus implantation . data regarding zsi 375 limited. retrospective, non-randomised trial across several centres europe, reported 84.4% success rate (19.3% dry rate 65.1% improved 0-1 pads per day) 43 months . 72% success rate reported seven years follow-up 45 patients underwent placement zsi 375 device france . retrospective study 168 patients receiving aus (ams 800 aus system) placements carried single surgeon 2008 2016 high-volume academic institution evaluated causes aus failure median follow-up initial placement 2.7 year. overall, 63 patients (37.5%) experienced aus failure requiring device explant/revision. pressure-regulating balloon malfunction, cuff malfunction, pump malfunction, urethral atrophy, urethral erosion, infection occurred 36.5%, 7.9%, 6.3%, 22.2%, 19.0% 12.7% aus failures, respectively. history previous pelvic radiotherapy, urethral stricture, urethral sling placement coronary artery disease independent predictors all-cause aus failure . retrospective review cases aus implantation performed 2005 2020 sixteen different french centres including patients primary implantation whose indication moderate severe sui radical prostatectomy (n= 417) bpo surgery (n=50) found similar social continence rates (zero one pad per day) three months groups (79% vs. 72%) . tolerability safety: artificial urinary sphincter complications include device infection/erosion (8.5%), mechanical failure (6.2%) urethral atrophy (7.9%) . multivariate analysis, radiation therapy independently associated risk urethral atrophy, older age longer time interval prostate cancer treatment aus surgery . urethral erosion associated previous irradiation penoscrotal approach . reported revision rates three years reason 10-29.1% [706,718-720]. risk urethral erosion zsi 375 aus 8.2-13.3% risk mechanical failure 2.2-2.5% . retrospective database comparison found significantly higher complication rates patients reported significantly higher patients undergoing aus implantation due ui following bpo surgery compared patients post-prostatectomy ui (8% vs. 18%, p=0.044). found clavien-dindo type 2 complication rate (20.6% vs. 44.4%, p=0.026) . practical considerations: artificial urinary sphincter efficacious improves qol men ppi. minimise complications, advised refer patients specialised centres experienced aus implementation. men considering insertion aus fully informed success intervention relies ability operate pump. treating physicians keep mind operating aus may become difficult men develop cognitive impairment lose manual dexterity. artificial urinary sphincter limited lifespan ‘maintenance’ re-operations common long-term. re-interventions classified complications . 5.6.5.3.2. non-circumferential compression device (proact®) mechanism action: proact® system consists two devices. device includes balloon, bi-lumen tubing, volume-adjustment port. devices introduced trocar via two small perineal incisions placed fluoroscopic guidance side bladder neck, close vesico-urethral anastomotic site. balloons filled, volume adjusted post-operatively using hypodermic needle injected intra-scrotal port. efficacy: sr meta-analysis nineteen studies including 1,264 patients reported 60.2% dry rate, significant reduction number pads used per day (-3.1) greatly improved qol scores proact® ; however, level heterogeneity among included studies high. comparison atoms proact®, showed former associated higher improvement satisfaction rates fewer complications . quasi-randomised trial comparing proact® bone-anchored male slings found resulted similar improvements sui (68% vs. 65%, respectively) . questionnaire study showed 50% patients still significantly bothered persistent incontinence following proact® . subgroup analysis radiotherapy patients reported worst outcomes compared patients receiving radiotherapy (46% vs. 68% success rate) well higher percentage urethral erosion proact® . tolerability safety: common intra-operative complication proact® implantation perforation bladder and/or urethra. meta-analysis estimated perforation rate 5.3% . estimated overall revision rate 22.2%, main causes erosion (3.8%), device leaking (4.1%) migration (6.5%) . prospective series shown adverse events frequent, leading explantation rate 11-58% [722,723,725-727]. practical considerations: proact® satisfactory rate success seems reasonable alternative treatment male ui; however, associated high complication rates. summary evidenceleprimary aus implantation effective cure sui men.1bprior pelvic radiotherapy likely negative impact outcomes aus implantation.3the non-circumferential compression device (proact®) effective treatment ppi sui; however, associated high failure complication rate leading frequent explantation particularly pelvic radiation therapy.2bthe rate explantation aus due infection erosion remains high (up 24% series).3explantation rate adjustable male slings seems superior fixed male sling based external comparisons4 recommendationsstrength ratingoffer artificial urinary sphincter (aus) men moderate-to-severe stress urinary incontinence.strongimplantation aus proact© men offered expert centres.weakwarn men receiving aus proact© that, although cure achieved high risk complications, mechanical failure, need explantation.strongdo offer non-circumferential compression device (proact©) men pelvic radiotherapy.weak